Anthem Biosciences Limited IPO Details – Price, Date, GMP & Analysis
Anthem Biosciences Limited IPO Overview
Key IPO Details
Investment Summary
The Anthem Biosciences Limited IPO IPO is a mainboard offering scheduled to open on July 14. The issue is priced at ₹570 per share, with a minimum application of 26 shares.
Status: Listed and trading
How to Apply for Anthem Biosciences Limited IPO
To apply for the Anthem Biosciences Limited IPO, you need a demat account with any SEBI-registered broker, PAN card, and UPI or bank account for payment.
Application Process
- Log into your broker's platform or app
- Navigate to IPO section and select Anthem Biosciences Limited IPO
- Enter bid quantity (minimum 26 shares)
- Choose cut-off price or enter specific price
- Make payment via UPI or ASBA
- Submit application before July 16
Required Documents
- Active demat account
- PAN card
- Bank account linked to demat
- UPI ID for payment
- Valid mobile number and email
Minimum Investment: ₹14,820(approx. based on lower price band)
Company Overview
Anthem Biosciences Limited, incorporated in 2006, is a technology-focused Contract Research, Development, and Manufacturing Organization (CRDMO) specializing in drug discovery, development, and manufacturing processes. The company serves a diverse clientele, including biotech firms and large pharmaceutical companies globally, and manufactures specialized fermentation-based APIs such as probiotics and enzymes. As of September 30, 2024, Anthem Biosciences had 196 projects and over 425 customers across 44 countries. The company holds one patent in India and seven overseas, with 24 pending global patent applications. Its team comprises 600 employees with expertise in various scientific fields.
Grey Market Premium (GMP)
IPO Timeline
Open Date
Mon, Jul 14, 2025
CompletedClose Date
Wed, Jul 16, 2025
CompletedAllotment
Thu, Jul 17, 2025
CompletedRefund Process
Fri, Jul 18, 2025
CompletedCredit to Demat
Fri, Jul 18, 2025
CompletedListing Date
Mon, Jul 21, 2025
CompletedSubscription Status
Latest Subscription Data
| Category | Subscription | Status |
|---|---|---|
| QIB (Qualified Institutional Buyers) | 192.80x | Oversubscribed |
| NII (Non-Institutional Investors/HNI) | 44.70x | Oversubscribed |
| RII (Retail Individual Investors) | 5.98x | Oversubscribed |
| Total Subscription | 67.42x | Oversubscribed |
Last updated: Invalid Date
IPO Details
Anthem Biosciences IPO Details
| IPO Date | July 14, 2025 to July 16, 2025 |
| Listing Date | July 21, 2025 |
| Face Value | ₹2 per share |
| Issue Price | ₹570 per share |
| Lot Size | 26 Shares |
| Sale Type | Offer For Sale |
| Total Issue Size | 5,95,75,319 shares (aggregating up to ₹3,395.79 Cr) |
| ₹50.00 | |
| Issue Type | Bookbuilding IPO |
| Listing At | BSE, NSE |
| Share Holding Pre Issue | 56,16,10,051 shares |
| Share Holding Post Issue | 56,16,10,051 shares |
Anthem Biosciences IPO Reservation
| Investor Category | Shares Offered | Maximum Allottees |
|---|---|---|
| QIB Shares Offered | 2,97,08,332 (49.87%) | NA |
| − Anchor Investor Shares Offered | 1,78,24,999 (29.92%) | NA |
| − QIB (Ex. Anchor) Shares Offered | 1,18,83,333 (19.95%) | NA |
| NII (HNI) Shares Offered | 89,12,500 (14.96%) | NA |
| − bNII > ₹10L | 59,41,667 (9.97%) | 16,323 |
| − sNII < ₹10L | 29,70,833 (4.99%) | 8,161 |
| Retail Shares Offered | 2,07,95,834 (34.91%) | 7,99,839 |
| Employee Shares Offered | 1,58,653 (0.27%) | NA |
Anthem Biosciences IPO Timeline (Tentative Schedule)
| IPO Open Date | Mon, Jul 14, 2025 |
| IPO Close Date | Wed, Jul 16, 2025 |
| Tentative Allotment | Thu, Jul 17, 2025 |
| Initiation of Refunds | Fri, Jul 18, 2025 |
| Credit of Shares to Demat | Fri, Jul 18, 2025 |
| Tentative Listing Date | Mon, Jul 21, 2025 |
| Cut-off time for UPI mandate confirmation | 5 PM on July 16, 2025 |
Anthem Biosciences IPO Lot Size
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 26 | ₹14,820 |
| Retail (Max) | 13 | 338 | ₹1,92,660 |
| S-HNI (Min) | 14 | 364 | ₹2,07,480 |
| S-HNI (Max) | 67 | 1,742 | ₹9,92,940 |
| B-HNI (Min) | 68 | 1,768 | ₹10,07,760 |
Anthem Biosciences IPO Promoter Holding
| Share Holding Pre Issue | 76.87% |
| Share Holding Post Issue | 74.68% |
Anthem Biosciences IPO Listing Details
| July 21, 2025 |
| 544449 |
| ANTHEM |
| INE0CZ201020 |
| ₹570 per share |
| EQ |
| B |
Financial Information
Company FinancialsAnthem Biosciences Ltd. Financial Information (Restated)
| Period Ended | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
| Assets | 2,807.58 | 2,398.11 | 2,014.46 |
| Revenue | 1,930.29 | 1,483.07 | 1,133.99 |
| Profit After Tax | 451.26 | 367.31 | 385.19 |
| EBITDA | 683.78 | 519.96 | 446.05 |
| Net Worth | 2,409.86 | 1,924.66 | 1,740.67 |
| Reserves and Surplus | 2,298.05 | 1,815.39 | 1,628.88 |
| Total Borrowing | 108.95 | 232.53 | 125.06 |
Key Dates
Anthem Biosciences Limited IPO IPO Review & Analysis
Should I Apply for Anthem Biosciences Limited IPO?
The Anthem Biosciences Limited IPO decision depends on your risk tolerance, investment goals, and analysis of company fundamentals. Consider factors like business model, financial performance, industry prospects, and valuation before applying.
Key Positives
- • Mainboard listing provides credibility
- • Issue size of ₹3,395.79 Cr indicates scale
- • Regulated by SEBI guidelines
Key Considerations
- • Analyze company financials thoroughly
- • Check Grey Market Premium trends
- • Consider market conditions
Anthem Biosciences Limited IPO Allotment Details
Allotment Timeline
How to Check Allotment
- • Visit registrar's official website
- • Enter PAN or application number
- • Check through broker's platform
- • Use our universal allotment tracker
Tip: Anthem Biosciences Limited IPO IPO allotment status will be available approximately 2-3 days after the issue closes. Successful applicants will receive shares in their demat account before listing.